Impact of High Bleeding Risk status on comparative outcomes of Physiology-guided Complete versus Culprit-Only Revascularization in older MI patients: Data from the FIRE trial

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker's Bureau - Sahajanand Medical Technologies Ltd.; Abbott; Medis Medical Imaging
• Grant Support/Research Contract - Abbott; Amgen; Medis Medical Imaging; GE Healthcare